These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 8496688)

  • 1. Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity.
    North RJ; Izzo AA
    J Exp Med; 1993 Jun; 177(6):1723-33. PubMed ID: 8496688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages.
    McDonough KA; Kress Y; Bloom BR
    Infect Immun; 1993 Jul; 61(7):2763-73. PubMed ID: 8514378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granuloma formation in severe combined immunodeficient (SCID) mice in response to progressive BCG infection. Tendency not to form granulomas in the lung is associated with faster bacterial growth in this organ.
    North RJ; Izzo AA
    Am J Pathol; 1993 Jun; 142(6):1959-66. PubMed ID: 8506962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors.
    Schlesinger LS
    J Immunol; 1993 Apr; 150(7):2920-30. PubMed ID: 8454864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of various strains of mycobacteria to killing by activated macrophages in vivo.
    Orme IM; Collins FM
    J Immunol; 1983 Sep; 131(3):1452-4. PubMed ID: 6411817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Mycobacterium bovis BCG vaccination on interleukin-1 beta and RANTES mRNA expression in guinea pig cells exposed to attenuated and virulent mycobacteria.
    Jeevan A; Yoshimura T; Foster G; McMurray DN
    Infect Immun; 2002 Mar; 70(3):1245-53. PubMed ID: 11854207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages.
    Zhang M; Gong J; Lin Y; Barnes PF
    Infect Immun; 1998 Feb; 66(2):794-9. PubMed ID: 9453643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of high and low antibody responder lines of mice to the growth of avirulent (BCG) and virulent (H37Rv) strains of mycobacteria.
    Gheorghiu M; Mouton D; Lecoeur H; Lagranderie M; Mevel JC; Biozzi G
    Clin Exp Immunol; 1985 Jan; 59(1):177-84. PubMed ID: 3882283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro.
    Paul S; Laochumroonvorapong P; Kaplan G
    J Infect Dis; 1996 Jul; 174(1):105-12. PubMed ID: 8655979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice.
    Dunn PL; North RJ
    Infect Immun; 1995 Sep; 63(9):3428-37. PubMed ID: 7642273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of granulomas in interferon-gamma gene-disrupted mice by avirulent but not by virulent strains of Mycobacterium tuberculosis.
    Sugawara I; Yamada H; Kazumi Y; Doi N; Otomo K; Aoki T; Mizuno S; Udagawa T; Tagawa Y; Iwakura Y
    J Med Microbiol; 1998 Oct; 47(10):871-7. PubMed ID: 9788810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages.
    Keane J; Remold HG; Kornfeld H
    J Immunol; 2000 Feb; 164(4):2016-20. PubMed ID: 10657653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependence of Mycobacterium bovis BCG on anaerobic nitrate reductase for persistence is tissue specific.
    Fritz C; Maass S; Kreft A; Bange FC
    Infect Immun; 2002 Jan; 70(1):286-91. PubMed ID: 11748194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice that carry the resistance allele of the Bcg gene (Bcgr) develop a superior capacity to stabilize bacille Calmette-Guerin (BCG) infection in their lungs and spleen over a protracted period in the absence of specific immunity.
    Medina E; North RJ
    Clin Exp Immunol; 1996 Apr; 104(1):44-7. PubMed ID: 8603532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of gene fadD33 for the growth of Mycobacterium tuberculosis in a hepatocyte cell line.
    Rindi L; Bonanni D; Lari N; Garzelli C
    New Microbiol; 2004 Apr; 27(2):125-31. PubMed ID: 15164622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions.
    Silver RF; Li Q; Ellner JJ
    Infect Immun; 1998 Mar; 66(3):1190-9. PubMed ID: 9488413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain virulence and the lysosomal response in macrophages infected with Mycobacterium tuberculosis.
    Hart PD; Armstrong JA
    Infect Immun; 1974 Oct; 10(4):742-6. PubMed ID: 4214780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaerobic nitrate reductase (narGHJI) activity of Mycobacterium bovis BCG in vitro and its contribution to virulence in immunodeficient mice.
    Weber I; Fritz C; Ruttkowski S; Kreft A; Bange FC
    Mol Microbiol; 2000 Mar; 35(5):1017-25. PubMed ID: 10712684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene.
    Berthet FX; Lagranderie M; Gounon P; Laurent-Winter C; Ensergueix D; Chavarot P; Thouron F; Maranghi E; Pelicic V; Portnoï D; Marchal G; Gicquel B
    Science; 1998 Oct; 282(5389):759-62. PubMed ID: 9784137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.